SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035526
Filing Date
2020-08-03
Accepted
2020-08-03 16:21:26
Documents
77
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20200630.htm 10-Q 1836356
2 EX-10.1 vtvt-ex101_220.htm EX-10.1 58693
3 EX-31.1 vtvt-ex311_7.htm EX-31.1 17630
4 EX-31.2 vtvt-ex312_10.htm EX-31.2 17524
5 EX-32.1 vtvt-ex321_8.htm EX-32.1 7259
6 EX-32.2 vtvt-ex322_9.htm EX-32.2 7214
7 GRAPHIC gmgzf44nvzh2000001.jpg GRAPHIC 27018
  Complete submission text file 0001564590-20-035526.txt   6806525

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vtvt-20200630.xml EX-101.INS 1349557
9 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20200630.xsd EX-101.SCH 62128
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20200630_cal.xml EX-101.CAL 46736
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20200630_def.xml EX-101.DEF 244718
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20200630_lab.xml EX-101.LAB 432656
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20200630_pre.xml EX-101.PRE 343526
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 201069492
SIC: 2834 Pharmaceutical Preparations